1National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990; 21: 637–76.
2Hankey, GJ, Warlow, CP. Transient ischaemic attacks of the brain and eye. London: Baillière Tindall, WB Saunders, 1994.
3Dennis, MS, Bamford, JM, Sandercock, PAG, Molyneux, A, Warlow, CP. Computerised tomography in patients with transient ischaemic attacks: when is a transient ischaemic attack not a transient ischaemic attack but a stroke? J Neurol 1990; 237: 257–61.
4Hatano, S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976; 54: 541–53.
5Bamford, J, Sandercock, P, Dennis, M, Burn, J, Warlow, C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981–1986. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral haemorrhage and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990; 53: 16–22.
6Anderson, CS, Jamrozik, KD, Burvill, PW, Chakera, TMH, Johnson, GA, Stewart-Wynne EG: Determining the incidence of different subtypes of stroke: results from the Perth Community Stroke study, 1989–1990. Med J Aust 1993; 158: 85–89.
7Dennis, MS, Bamford, JM, Sandercock, PAG, Warlow, CP. A comparison of risk factors and prognosis for transient ischaemic attacks and minor ischaemic strokes. The Oxfordshire Community Stroke Project. Stroke 1989; 20: 1494–99.
8Dennis, M, Bamford, J, Sandercock, P, Warlow, C. Prognosis of transient ischaemic attacks in the Oxfordshire Community Stroke Project. Stroke 1990; 21: 848–53.
9Hankey, GJ, Slattery, JM, Warlow, CP. The prognosis of hospital-referred transient ischaemic attacks. J Neural Neurosurg Psychiatry 1991; 54: 793–802.
10Dennis, MS, Burn, JPS, Sandercock, PAG, Bamford, JM, Wade, DT, Warlow, CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke 1993; 24: 796–800.
11Erkinjuntti, T, Hachinski, VC: Rethinking vascular dementia. Cerebrovasc Dis 1993; 3: 3–23.
12Secretary of State for Health. The Health of the Nation. London: HMSO, 1991.
13Martin, J, Meltzer, H, Elliot, D. For the Office of population censuses and surveys: OPCS surveys of disability in Great Britain, Report 1. The prevalence of disability among adults. London: HMSO, 1988.
14Bamford, J, Sandercock, P, Dennis, M et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981–1986. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry 1988; 51: 1373–80.
15Anderson, CS, Jamrozik, KD, Burvill, PW, Chakera, TMH, Johnson, GA, Stewart-Wynne EG. Ascertaining the true incidence of stroke: experience from the Perth Community Stroke Study, 1989–1990. Med J Aust 1993; 158: 80–84.
16Wade, DT, Langton-Hewer, R, Skilbeck, CE, David, RM. Stroke. A critical approach to diagnosis, treatment and management. London: Chapman & Hall, 1985.
17Bonita, RB, Beaglehole, R. Explaining stroke mortality trends. Lancet 1993; 341: 1510–11.
18Malmgren, R, Bamford, J, Warlow, C, Sandercock, P, Slattery, J. Projecting the number of patients with first-ever strokes and patients newly handicapped by stroke in England and Wales. Br Med J 1989; 298: 656–60.
19Carstairs, V. Stroke: resource consumption and the cost to the community. In: Gillingham, FJ, Mawdsley, C, Williams, AE eds. Stroke proceedings of the ninth international Pfizer symposium. Edinburgh: Churchill Livingstone, 1976: 516–28.
20Isard, PA, Forbes, JF. The cost of stroke to the National Health Service in Scotland. Cerebrovasc Dis 1992; 2: 47–50.
21Hankey, GJ, Warlow, CP. The role of imaging in the management of cerebral and ocular ischaemia. Neuroradiology 1991; 33: 381–90.
22Dennis, MS, Bamford, JM, Sandercock, PAG, Warlow, CP. Incidence of transient ischaemic attacks in Oxfordshire, England. Stroke 1989; 20: 333–39.
23Kraaijeveld, CL, van Gijn, J, Schouten, HJA, Staal, A. Interobserver agreement for the diagnosis of transient ischaemic attacks. Stroke 1984; 15: 723–25.
24Kessler, C, Freyberger, HJ, Dittmann, V, Ringelstein, EB. Interrater reliability in the assessment of neurovascular diseases. Cerebrovasc Dis 1991; 1: 43–48.
25Dennis, MS, Warlow, CP. Migraine aura without headache: transient ischaemic attack or not? J Neural Neurosurg Psychiatry 1992; 55: 437–40.
26Olesen, J, Friberg, L, Olsen, TK et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain 1993; 116: 187–202.
27O'Sullivan, F, Rossor, M, Elston, JS. Amaurosis fugax in young people. Br J Ophthalmol 1992; 76: 660–62.
28Rao, ML, Stefan, H, Bauer, J. Epileptic but not psychogenic seizures are accompanied by simultaneous elevation of serum pituitary hormones and cortisol levels. Neuroendocrinology 1989; 49: 33–39.
29Hodges, JR, Warlow, CP. Syndromes of transient amnesia: towards a classification. A study of 153 cases. J Neural Neurosurg Psychiatry 1990; 53 834–43.
30UK-TIA Study Group. Intracranial tumours that mimic transient cerebral ischaemia: lessons from a large multicentre trial. J Neural Neurosurg Psychiatry 1993; 56: 563–66.
31Bogousslavsky, J, Vinuela, F, Barnett, HJM, Drake, CG: Amaurosis fugax as the presenting manifestation of dural arteriovenous malformation. Stroke 1985; 16: 891–93.
32Moster, ML, Johnston, DE, Reinmuth, OM. Chronic subdural haematoma with transient neurological deficits: a review of 15 cases. Ann Neurol 1983; 14: 539–42.
33Twomey, JA, Espir, MLE. Paroxysmal symptoms as the first manifestations of multiple sclerosis. J Neural Neurosurg Psychiatry 1980; 43: 296–304.
34Rother, J, Schreiner, A, Wentz, K-U, Hennerici, M. Hypoglycaemia presenting as basilar artery thrombosis. Stroke 1992; 23: 112–13.
35Longo, DL, Witherspoon, JM. Focal neurological symptoms in hypercalcaemia. Neurology 1980; 30: 200–201.
36Ruby, RJ, Burton, JR. Acute reversible hemiparesis and hyponatraemia. Lancet 1977; 1: 1212.
37Dawson, DM, Hallett, M, Millender, LH. Entrapment neuropathies, second edition. Boston: Little, Brown & Co, 1990: 333.
38Blau, JN, Wiles, CM, Solomon, FS. Unilateral somatic symptoms due to hyperventilation. Br Med J 1983; 286: 1108.
39Bogousslavsky, J, Regli, F. Vertebrobasilar transient ischaemic attacks in internal carotid artery occlusion or tight stenosis. Arch Neurol 1985; 42: 64–68.
40Sandercock, PAG, Allen, CMC, Corston, RN, Harrison, MJG, Warlow, CP. Clinical diagnosis of intracranial haemorrhage using Guy's Hospital score. Br Med J 1985; 291: 1675–77.
41Poungvarin, N, Viriyavejakul, A, Komontri, C. Siriraj stroke score and validation study to distinguish supratentorial intracerebral haemorrhage from infarction. Br Med J 1991; 302: 1565–67.
42Donnan, GA. Investigation of patients with stroke and transient ischaemic attacks. Lancet 1992; 339: 473–77.
43Dennis, MS, Bamford, JM, Molyneux, AJ, Warlow, CP. Rapid resolution of signs of primary intracerebral haemorrhage in computed tomograms of the brain. Br Med M 1987;295: 379–81.
44Edelman, RR, Warach, S. Magnetic resonance imaging (second of two parts). N Engl J Med 1993; 328: 785–91.
45Hopkins, A, Menken, M, DeFriese, GH, Feldman, RG. Differences in strategies for the diagnosis and treatment of neurologic disease among British and American neurologists. Arch Neurol 1989; 46: 1142–48.
46UK-TIA Study Group. Variation in the use of angiography and carotid endarterectomy by neurologists in the UK-TIA Aspirin Trial. Br Med J 1983; 286: 514–17.
47Hankey, GJ, Warlow, CP. Cost-effective investigation of patients with suspected transient ischaemic attacks. J Neural Neurosurg Psychiatry 1992; 55: 171–76.
48Caplan, LR. Intracerebral haemorrhage. Lancet 1992; 339: 656–58.
49van Gijn, J. Subarachnoid haemorrhage. Lancet 1992; 339: 653–55.
50Donnan, GA, Bladin, PF, Berkovic, SF, Longley, WA, Saling, MM. The stroke syndrome of striatocapsular infarction. Brain 1991; 114: 51–70.
51Hankey, GJ, Warlow, CP. Lacunar transient ischaemic attacks: a clinically useful concept? Lancet 1991; 337: 335–38.
52Hommel, M, Besson, G, Le Bas, JF et al. Prospective study of lacunar infarction using magnetic resonance imaging. Stroke 1990; 21: 546–54.
53Waterston, JA, Brown, MM, Butler, P, Swash, M. Small deep cerebral infarcts associated with occlusive internal carotid artery disease. Arch Neurol 1990; 47: 953–57.
54Hankey, GJ, Khangure, MS, Stewart-Wynne, EG. Detection of basilar artery thrombosis by computed tomography. Clin Radiol 1988; 39: 140–43.
55Virapongse, C, Cazenave, C, Quisling, R, Sarwar, M, Hunter, S. The empty delta sign. Frequency and significance in 76 cases of dural sinus thrombosis. Radiology 1987; 162: 779–85.
56Woo, J, Lam, CWK, Kay, R, Wong, HY, Teoh, R, Nicholls MG. Acute and long-term changes in serum lipids after acute stroke. Stroke 1990; 21: 1407–11.
57Sandercock, PAG, Warlow, CP, Jones, LN, Starkey, IR. Predisposing factors for cerebral infarction: the Oxfordshire community stroke project. Br Med J 1989; 298: 75–80.
58Hughes, GRV: The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341–44.
59Greaves, M. Coagulation abnormalities and cerebral infarction. J Neurol Neurosurg Psychiatry 1993; 56: 433–39.
60European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 1991; 337: 1235–43.
61North American Symptomatic Carotid Endarterectomy Trial (NASCET) collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445–53.
62Hankey, GJ, Warlow, CP. Symptomatic carotid ischaemic events: safest and most cost-effective way of selecting patients for angiography, before carotid endarterectomy. Br Med J 1990; 300: 1485–91.
63Hu, H-H, Sheng, W-Y, Yen, M-Y, Lai, S-T, Teng, MM-H: Colour Doppler imaging of orbital arteries for detection of carotid occlusive disease. Stroke 1993;24: 1196–203.
64Humphrey, P, Sandercock, P, Slattery, J. A simple method to improve the accuracy of non-invasive ultrasound in selecting TIA patients for cerebral angiography. J Neurol Neurosurg Psychiatry 1990; 53: 966–71.
65Lewis, BD, James, EM, Welch, TJ. Current applications of Duplex and color Doppler ultrasound imaging: carotid and peripheral vascular system. Mayo Clin Proc 1989; 64: 1147–57.
66Carroll, BA: Carotid sonography. Radiology 1991; 178: 303–13.
67Steinke, W, Hennerici, M, Rautenberg, W, Mohr, JP. Symptomatic and asymptomatic high-grade stenoses in Doppler colour-flow imaging. Neurology 1992; 42: 131–38.
68Hankey, GJ, Warlow, CP, Sellar, RJ. Cerebral angiographie risk in mild cerebrovascular disease. Stroke 1990; 21: 209–22.
69Hankey, GJ, Warlow, CP, Molyneux, AJ. Complications of cerebral angiography for patients with mild carotid territory ischaemia being considered for carotid endarterectomy. J Neurol Neurosurg Psychiatry 1990; 53: 542–48.
70Davies, KN, Humphrey, PR. Complications of cerebral angiography in patients with symptomatic carotid territory ischaemia screened by carotid ultrasound. J Neurol Neurosurg Psychiatry 1993; 56: 967–72.
71Hart, RG. Cardiogenic embolism to the brain. Lancet 1992; 339: 589–94.
72DeRook, FA, Comess, KA, Albers, GW. Popp, RL. Transoesophageal echocardiography in the evaluation of stroke. Ann Intern Med 1992; 117: 922–32.
73Rose, G. The strategy of preventive medicine. Oxford: Oxford University Press, 1992.
74Shaper, AG, Phillips, AN, Pocock, SJ, Walker, M, Macfarlane, PW. Risk factors for stroke in middle aged British men. Br Med J 1991; 302: 1111–15.
75Donnan, GA, You, R, Thrift, A, McNeil, JJ. Smoking as a risk factor for stroke. Cerebrovasc Dis 1993; 3: 129–38.
76Alderman, MH. Blood pressure management: individualised treatment based on absolute risk and the potential for benefit. Ann Intern Med 1993; 119: 329–35.
77MacMahon, S, Peto, R, Cutler, J et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–74.
78Collins, R, Peto, R, MacMahon, S et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–38.
79Hankey, GJ, Slattery, JM, Warlow, CP. Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events? J Neural Neurosurg Psychiatry 1992; 55: 640–52.
80Antiplatelet Trialists Collaboration: Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81–106.
81The SALT Collaborative Group (Britton, M, Elwin, C-E, Helmers, C et al. ) Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischemie events. Lancet 1991; 338: 1345–49.
82The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 versus 283 mg a day) in patients after a transient ischaemic attack or minor ischaemic stroke. N Engl J Med 1991; 325: 1261–66.
83European Atrial Fibrillation Trial Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255–62.
84Petersen, P, Boysen, G, Godfredsen, J, Andersen, E, Andersen, B. Placebo-controlled randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet 1988; 1: 175–79.
85The Stroke Prevention in Atrial Fibrillation Study Group. The stroke prevention in atrial fibrillation study: final results. Circulation 1991; 84: 527–39.
86The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505–11.
87Connolly, SJ, Laupacis, A, Gent, M, Roberts, RS, Cairns, JA, Joyner, C, for the CAFA Study Coinvestigators. Canadian atrial fibrillation anticoagulation (CAFA) study. J Am Coll Cardiol 1991; 18: 349–55.
88Ezekowitz, MD, Bridgers, SL, James, KE et al. for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation (SPINAF) Investigators. Warfarin in the prevention of stroke associated with atrial fibrillation. N Engl J Med 1992; 327: 1406–f12.
89Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343: 687–91.
90Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: clinical features of patients at risk. Ann Intern Med 1992; 116: 1–5.
91Clagett, GP, Youkey, JR, Brigham, RA et al. Asymptomatic cervical bruit and abnormal ocular plethysmography: a prospective study comparing two approaches to management. Surgery 1984; 96: 823–30.
92The CASANOVA Study Group. Carotid surgery versus medical therapy in asymptomatic carotid stenosis. Stroke 1991; 22: 1229–35.
93Mayo Asymptomatic Carotid Endarterectomy Group. Results of a randomised controlled trial of carotid endarterectomy for asymptomatic carotid stenosis. Mayo Clin Proc 1992; 67: 513–18.
94Hobson, RW II, Weiss, DG, Fields WS et al. and the Veterans Affairs Cooperative Group. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1993; 328: 221–27.
95Asymptomatic Carotid Atherosclerosis Study Group. Study design for randomised prospective trial of carotid endarterectomy for asymptomatic atherosclerosis. Stroke 1989; 20: 844–49.
96EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischaemic stroke. N Engl J Med 1985; 313: 1191–200.
97Brown, MM, Butler, P, Gibbs, J, Swash, M, Waterston, J. Feasibility of percutaneous transluminal angioplasty for carotid artery stenosis. J Neurol Neurosurg Psychiatry 1990; 53: 238–43.
98Sandercock, P, Willems, H. Medical treatment of acute ischaemic stroke. Lancet 1992; 339: 537–39.
99Wardlaw, JM, Warlow, CP. Thrombolysis in acute ischaemic stroke. Does it work? Stroke 1992; 23: 1826–39.
100Sandercock, PAG, van den Belt, AGM, Lindley, RI, Slattery, J. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. J Neurol Neurosurg Psychiatry 1993; 56: 17–25.
101Scatton, B, Carter, C, Benavides, J, Giroux, C. N-Methyl-D-Aspartate receptor antagonists: a novel therapeutic perspective for the treatment of ischaemic brain injury. Cerebrovasc Dis 1991; 1: 121–35.
102Czlonkowska, A, Mendel, T, Baranska-Gieruszcak, M. Naloxone in acute ischaemic stroke: double blind controlled study. J Neurol 1990; 237: 153.
103Schmidley, JW. Free radicals in central nervous system ischaemia. Stroke 1990; 21: 1086–90.
104Argentino, C, Sacchetti, ML, Toni, D et al. GM1 Ganglioside therapy in acute ischaemic stroke. Stroke 1989; 20: 1143–49.
105Goldstein, LB, Davis, JN. Restorative neurology. Drugs and recovery following stroke. Stroke 1990; 21: 1636–39.
106Pickard, JD, Murray, GD, Illingworth, R et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage. British aneurysm nimodipine trial. Br Med J 1989; 298: 636–42.